Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with BMY: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
BMY
Bristol Myers Squibb Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
BMY
Bristol Myers Squibb Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
LLY
3 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±5.1%
▲
+6.63%
×1.29
Q2 FY26
±6.2%
▲
+4.86%
×0.79
Q1 FY26
±5.3%
▲
+9.80%
×1.85
Feb 4 '26
±6.1%
▲
+10.33%
×1.69
BMY
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.6%
▲
+1.35%
×0.39
Q2 FY26
±3.7%
▲
+2.79%
×0.76
= implied
LLY realized, solid
BMY realized, hatched
One scale, both sides: full bar = 11%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±4.1%
▲
+5.21%
×1.27
Feb 5 '26
±3.8%
▲
+3.30%
×0.87
LLY
ELI Lilly & Co
Change
1,371.17
▲
+0.47%
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
BMY
Bristol Myers Squibb Co
Change
62.71
▼
−0.67%
Regular session
Nov 6 '26
Mkt cap
$129.0B
Revenue
$13.1B
Q3 FY26
Revenue
$48.2B
FY25
vs
Compare
Regular session
Nov 6 '26
LLY
ELI Lilly & Co
vs
BMY
Bristol Myers Squibb Co
1,371.17
▲
+0.47%
Price
62.71
▼
−0.67%
$1.2T
Mkt cap
$129.0B
Q3 FY26
$24.4B
Revenue
$13.1B
Q3 FY26
FY25
$65.2B
Revenue
$48.2B
FY25
Change
Change
LLY
1,371.17
▲
+0.47%
vs
BMY
62.71
▼
−0.67%
Regular session
Nov 6 '26